TY  - JOUR

T1  - DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma.

JO  - Journal of Clinical Oncology

PY  - 2013/05/20

AU  - Gupta A

AU  - Love S

AU  - Schuh A

AU  - Collins L

AU  - Thomason A

AU  - Asher R

AU  - Lisle R

AU  - Churchman M

AU  - Shanyinde M

AU  - Plummer R

AU  - Nathan PD et al

ED  - 

DO  - DOI: 10.1200/jco.2013.31.15_suppl.9068

PB  - American Society of Clinical Oncology (ASCO)

VL  - 31

IS  - 15_suppl

SP  - 9068

EP  - 9068

Y2  - 2024/09/19

ER  -